Why the study?
Does a fixed combination of perindopril/indapamide improve blood pressure and cardiovascular remodeling in patients with grade 1-2 arterial hypertension?
Does a fixed combination of perindopril/indapamide improve blood pressure and cardiovascular remodeling in patients with grade 1-2 arterial hypertension?
A fixed combination of perindopril and indapamide over 12 months effectively lowers blood pressure and improves cardiovascular remodeling in patients with grade 1-2 hypertension.
Answers are grounded in this paper and cite their sources.
Supports perindopril/indapamide fixed combination in grade 1-2 hypertension; extends RCT evidence for cardiovascular remodeling benefits.
Objective. To estimate vaso- and organoprotective effects of a fixed low- and full-dose combination of perindopril/indapamid in hypertensive patients. Design and methods. 56 patients with arterial hypertension of the 1-2 degrees (AH 1-2) aged 50,6 ± 0,6 years old, and 25 healthy volunteers were included into an open randomized investigation. A single dose of a fixed low- and full-dose combination of perindopril/indapamid (Servier, France) was administered for a period of 12 months. The following parameters were monitored dynamically: office blood pressure (BP), internal patients' state, endothelial function, aorta and large arteries stiffness, indices reflecting remodeling of the heart, renal and cerebral blood vessels (echocardiogram, sonography of renal and cerebral blood vessels at the device ALOKA 4000 with TRIPLEX-scanning), microalbuminuria and glomerular filtration rate. Results. By the end of the 12 th month of the therapy with the fixed low- and full-dose combination of perindopril/indapamid 96,3 % of the AH 1 patients and 86,2 % AH 2 patients have reached the target blood pressure level; a high compliance had been observed (92-99 %), the beneficial drug effects on the remodeling of heart (decrease of the left ventricle myocardial mass index, p < 0,05) and blood vessels (stiffness reduction, the increase of aorta extension, and endothelial function restoration) were found. The antihypertensive therapy resulted in the reduction of hypertensive nephropathy and encephalopathy, and cerebrovascular reactivity improvement. Conclusion. A long-term therapy with a fixed low- and full-dose combination of perindopril/indapamid in patients with arterial hypertension of the 1-2 degrees leads to the reverse cardiovascular remodeling providing with a vaso- and organoprotective effects as well as the target BP achieving.
No takes yet. Share an insight, caveat, or question.
Логачева et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: